Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 22.51%2.38B | ---- | -11.05%1.94B | ---- | 0.14%2.18B | ---- | 245.06%2.18B | ---- | 20.06%631.07M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -85.32%-42.95M | ---- | 36.84%-23.17M | ---- | -67.86%-36.69M | ---- | -16.82%-21.86M | ---- | 2.69%-18.71M |
| Investment loss (gain) | ---- | -10.19%-238K | ---- | 60.80%-216K | ---- | -170.10%-551K | ---- | 92.46%-204K | ---- | 53.92%-2.71M |
| Attributable subsidiary (profit) loss | ---- | -144.21%-1.62M | ---- | 85.78%-665K | ---- | -279.46%-4.68M | ---- | -311.68%-1.23M | ---- | 125.33%582K |
| Impairment and provisions: | ---- | 62.35%43.03M | ---- | -29.02%26.51M | ---- | 20.17%37.34M | ---- | -74.21%31.08M | ---- | 952.19%120.48M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | --4.82M | ---- | ---- | ---- | -94.82%5.86M | ---- | --113.11M |
| -Impairmen of inventory (reversal) | ---- | 60.86%19.91M | ---- | -55.05%12.38M | ---- | 158.56%27.54M | ---- | 516.68%10.65M | ---- | 19.68%1.73M |
| -Impairment of goodwill | ---- | --3.41M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | 111.72%19.71M | ---- | -5.06%9.31M | ---- | -32.70%9.81M | ---- | 158.33%14.57M | ---- | -43.64%5.64M |
| Revaluation surplus: | ---- | -71.67%617K | ---- | 72.99%2.18M | ---- | -57.86%1.26M | ---- | -37.89%2.99M | ---- | -66.52%4.81M |
| -Derivative financial instruments fair value (increase) | ---- | 133.65%604K | ---- | ---1.8M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other fair value changes | ---- | -99.67%13K | ---- | 215.57%3.97M | ---- | -57.86%1.26M | ---- | -37.89%2.99M | ---- | -66.52%4.81M |
| Asset sale loss (gain): | ---- | -125,681.63%-724.61M | ---- | -98.47%577K | ---- | -18.04%37.75M | ---- | 283.61%46.06M | ---- | 28.92%-25.09M |
| -Available for sale investment sale loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.19M |
| -Loss (gain) from sale of subsidiary company | ---- | ---739.53M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 2,486.83%14.93M | ---- | -98.48%577K | ---- | -18.32%38.07M | ---- | 270.86%46.61M | ---- | 7.04%-27.28M |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | 42.36%-317K | ---- | ---550K | ---- | ---- |
| Depreciation and amortization: | ---- | 8.85%1.67B | ---- | 7.56%1.54B | ---- | 32.47%1.43B | ---- | 36.92%1.08B | ---- | 5.80%786.9M |
| -Amortization of intangible assets | ---- | 40.39%15.64M | ---- | -12.49%11.14M | ---- | 12.52%12.73M | ---- | 26.43%11.31M | ---- | 9.18%8.95M |
| -Other depreciation and amortization | ---- | 189.71%4.96M | ---- | 153.10%1.71M | ---- | -170.30%-3.22M | ---- | 89.72%-1.19M | ---- | -315.16%-11.6M |
| Financial expense | ---- | -14.65%495.04M | ---- | -12.41%579.99M | ---- | 13.51%662.19M | ---- | 45.34%583.37M | ---- | 7.30%401.38M |
| Exchange Loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 98.57%-460K | ---- | -715.54%-32.08M |
| Special items | ---- | 692.92%67.53M | ---- | -32.10%8.52M | ---- | -22.72%12.54M | ---- | 286.91%16.23M | ---- | 256.47%4.2M |
| Adjustment items | ---- | ---- | ---- | ---- | ---- | 4.73%-9.67M | ---- | 19.87%-10.15M | ---- | -57.37%-12.67M |
| Operating profit before the change of operating capital | ---- | -4.53%3.88B | ---- | -5.54%4.07B | ---- | 10.42%4.31B | ---- | 109.93%3.9B | ---- | 16.10%1.86B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -260.28%-145.23M | ---- | 175.76%90.61M | ---- | 80.89%-119.61M | ---- | -1,497.88%-625.89M | ---- | -48.59%44.77M |
| Accounts receivable (increase)decrease | ---- | -94.63%3.21M | ---- | -82.60%59.81M | ---- | 360.60%343.74M | ---- | -245.44%-131.9M | ---- | -67.16%90.69M |
| Accounts payable increase (decrease) | ---- | -84.90%153.08M | ---- | 858.07%1.01B | ---- | -69.74%105.8M | ---- | 115.72%349.69M | ---- | -64.96%162.1M |
| Special items for working capital changes | ---- | -121.67%-113M | ---- | 602.96%521.57M | ---- | 79.17%-103.7M | ---- | -21.50%-497.95M | ---- | -964.70%-409.84M |
| Cash from business operations | -39.60%1.38B | -34.27%3.78B | -21.98%2.28B | 26.92%5.75B | 61.43%2.92B | 51.38%4.53B | 23.64%1.81B | 71.53%2.99B | 130.74%1.46B | -26.89%1.75B |
| Other taxs | 13.64%-229.72M | -42.03%-454.78M | 22.59%-266M | -66.68%-320.19M | 39.20%-343.6M | 27.75%-192.1M | -195.94%-565.1M | -200.41%-265.88M | -229.04%-190.95M | 20.79%-88.51M |
| Interest received - operating | -49.59%6.91M | 1.34%22.14M | 9.87%13.71M | -27.84%21.84M | 54.23%12.48M | 68.20%30.27M | -16.32%8.09M | -8.96%18M | 94.82%9.67M | 8.78%19.77M |
| Special items of business | 90.68%93.84M | ---- | 166.97%49.21M | ---- | -7.52%18.43M | 4,537.39%10.67M | 75.69%19.93M | -99.14%230K | 281.09%11.35M | 282.12%26.86M |
| Net cash from operations | -39.91%1.25B | -38.60%3.35B | -20.41%2.08B | 24.49%5.46B | 105.01%2.61B | 59.53%4.38B | -1.64%1.27B | 61.22%2.75B | 121.43%1.29B | -25.96%1.7B |
| Cash flow from investment activities | ||||||||||
| Sale of fixed assets | -99.30%5.69M | -22.17%11.37M | 2,368.03%814.55M | -76.44%14.61M | -19.72%33M | -51.51%62.01M | 837.09%41.11M | 7.73%127.88M | -73.16%4.39M | 163.52%118.71M |
| Purchase of fixed assets | -34.90%-2.56B | -37.15%-4.6B | -9.04%-1.89B | 10.62%-3.35B | -8.86%-1.74B | 1.00%-3.75B | 4.74%-1.6B | 3.36%-3.79B | 10.81%-1.68B | -36.75%-3.92B |
| Selling intangible assets | ---- | ---- | ---- | ---- | ---- | -90.18%267K | ---- | --2.72M | ---- | ---- |
| Purchase of intangible assets | 93.84%-10.25M | -20.41%-276.42M | 5.27%-166.26M | -3,135.53%-229.56M | -1,656.31%-175.51M | 75.03%-7.1M | ---9.99M | -207.12%-28.42M | ---- | -66.03%-9.25M |
| Sale of subsidiaries | --487.9M | --724.99M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | -2,555.55%-154.37M | ---- | ---5.81M | ---- | ---- | ---- | ---- | ---- | -843.49%-62.53M |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -12.04%5.81M | ---- | -91.89%6.61M |
| Cash on investment | ---- | ---- | ---- | -37.83%-22.93M | ---- | -216.03%-16.64M | ---- | 82.51%-5.26M | ---10.28M | 94.22%-30.1M |
| Other items in the investment business | ---- | 117.71%1.59M | ---- | 20.16%-9M | ---- | 72.65%-11.27M | ---- | -817.10%-41.2M | ---- | -176.49%-4.49M |
| Net cash from investment operations | -66.27%-2.07B | -19.02%-4.29B | 33.70%-1.25B | 3.18%-3.61B | -20.13%-1.88B | 0.10%-3.72B | 6.92%-1.57B | 4.47%-3.73B | 16.76%-1.68B | -18.71%-3.9B |
| Net cash before financing | -199.68%-825.84M | -150.85%-941.1M | 13.96%828.49M | 180.91%1.85B | 347.84%727.01M | 167.21%658.83M | 24.48%-293.34M | 55.40%-980.23M | 72.95%-388.44M | -123.06%-2.2B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 52.50%7.46B | 15.83%10.8B | 0.23%4.89B | -16.45%9.32B | -17.89%4.88B | 42.35%11.16B | 41.99%5.94B | -0.09%7.84B | -4.45%4.19B | 50.97%7.84B |
| Refund | -18.67%-4.78B | 4.28%-9.54B | 23.85%-4.03B | 2.47%-9.97B | -49.75%-5.29B | -76.74%-10.22B | -6.00%-3.53B | -13.37%-5.78B | -32.08%-3.33B | -26.65%-5.1B |
| Issuing shares | ---- | --98.43M | ---- | ---- | ---- | --298.41M | ---- | ---- | ---- | ---- |
| Issuance of bonds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -50.00%97M |
| Interest paid - financing | 11.60%-222.8M | 23.92%-495.25M | 21.74%-252.04M | -2.23%-650.97M | -8.58%-322.06M | -13.39%-636.74M | -6.04%-296.6M | -59.43%-561.57M | -38.51%-279.72M | -3.64%-352.24M |
| Dividends paid - financing | 80.15%-88.55M | 5.74%-449.43M | -28.62%-446.14M | -32.18%-476.81M | -429.70%-346.87M | -76.54%-360.72M | -95.13%-65.48M | 1.65%-204.33M | 46.47%-33.56M | -11.13%-207.76M |
| Absorb investment income | ---- | 482.49%542.19M | ---- | 15.00%93.08M | ---- | 65.31%80.94M | ---- | -79.03%48.96M | ---- | -70.69%233.48M |
| Issuance expenses and redemption of securities expenses | ---- | 93.14%-23.03M | ---- | -67.86%-335.72M | ---- | ---200M | ---- | ---- | ---- | ---500M |
| Pledged bank deposit (increase) decrease | ---- | -84.31%26.42M | ---- | 279.71%168.4M | ---- | --44.35M | ---- | ---- | ---- | 1,431.57%93.87M |
| Other items of the financing business | 50.09%-70.49M | 21.43%-232.7M | -245.43%-141.23M | -25.03%-296.18M | 110.45%97.11M | -145.90%-236.88M | -8,972.25%-928.91M | ---96.33M | 79.52%-10.24M | ---- |
| Net cash from financing operations | 9,872.42%2.3B | 130.85%665.77M | 102.34%23.03M | -2,525.98%-2.16B | -187.84%-983.05M | -106.90%-82.18M | 111.55%1.12B | -40.30%1.19B | -69.64%529.03M | 30.97%2B |
| Other items affecting net cash | ---- | ---- | ---1K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net Cash | 72.72%1.47B | 10.38%-275.33M | 432.57%851.52M | -153.27%-307.21M | -131.00%-256.04M | 173.20%576.65M | 487.40%825.83M | 204.28%211.08M | -54.12%140.59M | -137.60%-202.41M |
| Begining period cash | -23.68%887.23M | -20.90%1.16B | -20.90%1.16B | 64.57%1.47B | 64.57%1.47B | 30.95%893.12M | 30.95%893.12M | -22.89%682.04M | -22.89%682.04M | 155.51%884.45M |
| Cash at the end | 17.07%2.36B | -23.68%887.23M | 65.94%2.01B | -20.90%1.16B | -29.39%1.21B | 64.57%1.47B | 108.96%1.72B | 30.95%893.12M | -30.92%822.63M | -22.89%682.04M |
| Cash balance analysis | ||||||||||
| Cash and cash equivalent balance | 17.07%2.36B | ---- | 65.94%2.01B | ---- | --1.21B | ---- | ---- | ---- | -30.92%822.63M | -22.89%682.04M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.